This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
[Retracted] lncRNA‑u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling
Wei Wei, Xiaoliang Zhao, Jianquan Zhu, Lianmin Zhang, Yulong Chen, Bin Zhang, Yue Li, Meng Wang, Zhenfa Zhang, Changli Wang
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer-related molecular mechanisms research · RNA modifications and cancer · Circular RNAs in diseases
Oncol Rep 42: 1946–1956, 2019; DOI: 10.3892/or.2019.7302
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the western blotting data shown in Fig. 4B and C on p. 1952, and the Transwell invasion assay data in Fig. 2F and 4I, had already appeared in previously published articles written by different authors at different research institutes (a number of which have been retracted). Owing to the fact that the contentious data in the above article had already been published prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.